BORTEZOMIB 3.5 MG VIAL

Bortezomib
$43.3460per EA

Strength

3.5 mg/1

NDC

31722030331

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

3/26/2025

Active Ingredients

BORTEZOMIB

Approval Type

Generic (ANDA)

FDA Application

ANDA212204

On Market Since

5/3/2024

Pharmacological Classes

Proteasome Inhibitor
Proteasome Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

N/A